Please login to the form below
Novartis sees five new $1bn-plus launches in next two years
CEO defends likely high price of Zolgensma
Still no breakthrough on Orkambi talks, MPs want answers
As other price deals go through, Orkambi stalled again
Amgen buys Danish partner Nuevolution for $167m
Copenhagen-based biotech will remain autonomous
Latecomer Lilly preps its IL-23 drug for Crohn’s disease
Hopes to leapfrog rivals
Merck bulks up in cancer with $2.2bn Peloton buy
Another significant bolt-on in oncology
Verily unveils next-gen trials alliance with Novartis, Pfizer
New data methods and tech will be used to streamline trials
Huntsworth bolsters market access capabilities with Creativ-Ceutical
Adds new capabilities and global presence
Boehringer eyes rare disease use for respiratory blockbuster
Would help support respiratory franchise
Q&A with Tim Cockroft
PME interviews the founding director of akt health communications
-
Q&A: Niels LundPME interviews Novo Nordisk's Vice President, Health Advocacy
-
PMEA names Dr Paul Stuart-Kregor as Chair of JudgesHe succeeds Professor Brian Smith
-
No deal or revoke looming as fourth vote on Brexit nearsVoters set to protest via EU elections, no-deal remains possibility
-
Research charity LifeArc cashes $1.2bn royalty from KeytrudaUK medical research charity pledges to expand its work
-
Keytruda monotherapy fails in triple negative breast cancerFails in gambit to outflank rival Tecentriq
-
RNA-focused biotech Storm Therapeutics raises extra £14mNew head of translational oncology also hired
-
Europe responding to gene therapy challenge, but picture remains fragmentedGermany, Italy and England using outcomes-based deals
-
Syncona launches another cell therapy company, Treg specialist QuellFocuses on novel immune system approach
-
MorphoSys eyes 2020 launch for lymphoma CAR-T challengerResults rival Kymriah and Yescarta - with less cost and complexity
Latest appointments
-
Health comms agency emotive hires new cell and gene therapy leaderNew division will cater to fast-expanding field
-
McCann Health bolsters European leadership teamNew hires will deepen the agency’s capabilities in the healthcare market
-
New faces at 11 London, ramarketing and MSLLatest movers in healthcare comms
-
Changes at Oxford PharmaGenesis, Synergy Vision and akt health communicationsThe latest movers in healthcare comms
-
Streaming Well to “raise the bar in pharma film making”Company appoints Steve Skinner and Freddie Slaughter to further its goal
Featured jobs
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Midweight Brand Planner
-
Up to £50, 000
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Senior Medical Writer
-
Salary TBC
- Head of Partnerships - Competitive - London
-
Competitive Salary Offered
Subscribe to our email news alerts
- Genfit presses the gas on NASH with combo trials
- PM Society Digital Award Finalists
- Novartis sees five new $1bn-plus launches in next two years
- Stung by critics, J&J says antidepressant Spravato saves money
- Still no breakthrough on Orkambi talks, MPs want answers
- Curiosity – did it ever really kill the cat?
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- PM Society Digital Award Finalists
- P&P are shortlisted for the ‘Craft in Film’ category at this year’s PM Society Digital Awards...
- The Exhibition Hall: Past, Present and Future
- As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
- Success breeds success
- This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Quick links
Infographics
